Differently, no significant IFN-γ value changes were observed in TB patients microbiologically confirmed (baseline: the median of TB1 peptides response: 1.7 IU/mL, IQR: 0.5–6.3; median of TB2 response: 1.8 IU/mL, IQR: 0.6–5.9) compared to end of therapy (1 IU/mL, IQR: 0.4–2.1 and 1.9 IU/mL, IQR: 0.3–3.3; respectively for TB1 and TB2) (Fig. 3C). The gene discussed is IFNG; the disease is tuberculosis.